Is Eversense the Latest Game Changer in the Diabetes Market?
Senseonics’ newly approved Eversense implantable continuous glucose monitoring (CGM) system could be in patient’s hands as early as next month. Tim Goodnow, the Germantown, MD-based company’s president and CEO spoke with MD+DI just a few hours removed from the start of the American Diabetes Association’s 78th Scientific Sessions in Orlando, FL. about the approval and upcoming plans for the device. “We think we’ll have our first patients on the product in the third week of July, so it will take us just about a month,” Goodnow, told MD+DI. “We’ve got to print some of the ...
Source: MDDI - June 22, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Implants Source Type: news

Senseonics Wins Nod for Implantable Long-Term CGM
Senseonics Holdings said it has received a PMA for the Eversense Continous Glucose Monitoring (CGM) system. The Germantown, Md-based company said the system is the first and only CGM to feature an implantable glucose sensor and provide long-term continuous monitoring for up to three months. “We’re very pleased to receive this FDA approval that allows us to make Eversense available in the U.S., as it is in many European markets,” Tim Goodnow President and CEO of Senseonics said in a release. “With the parallel trends of wearable personal devices and medical implantables for people to manage their hea...
Source: MDDI - June 21, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Source Type: news

WATCH: Survivors of pancreatic cancer bring their fight to Capitol Hill
Members of the Pancreatic Cancer Action Network are lobbying for more research in Washington, D.C. (Source: ABC News: Health)
Source: ABC News: Health - June 21, 2018 Category: Consumer Health News Tags: US Source Type: news

Caris Life Sciences Presents Data Demonstrating the Ability of ADAPT Biotargeting System to Identify Responders and Non-Responders in a Phase III Pancreatic Cancer Study
Leveraging ADAPT Biotargeting System would have significantly increased the probability of success Data presented at the ESMO World Congress on Gastrointestinal Cancer 2018 IRVING, Texas, June 21, 2018 -- (Healthcare Sales & Marketing Network) -- Ca... Diagnostics, Oncology Caris Life Sciences, ADAPT Biotargeting System, precision medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2018 Category: Pharmaceuticals Source Type: news

Genetic Testing in Relatives of Pancreatic Cancer Patients? Genetic Testing in Relatives of Pancreatic Cancer Patients?
Genetic testing guidelines in pancreatic cancer are urgently needed for patients with pancreatic cancer and their worried relatives.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - June 21, 2018 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Medical News Today: What to know about lipase tests and the pancreas
A doctor will order a lipase test if they suspect that a person has a problem with their pancreas. When the pancreas is inflamed, it often produces more lipase than usual. If the results of a lipase test show high levels, a person may have pancreatitis. Learn more about lipase levels and how to lower them here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 20, 2018 Category: Consumer Health News Tags: Endocrinology Source Type: news

Monitoring is Key in Precipio ’s Liquid Biopsy Success
The liquid biopsy market has expanded greatly in the past few years. From billion-dollar financings to highly publicized spinouts – the space has managed to attract quite a bit of attention and change the dynamic of diagnostics. Earlier this week, Roche made a big play in the space by acquiring the remaining shares of Foundation Medicine for $2.4 billion. Precipio is hoping to make its own impact in liquid biopsy and said it is focused on the monitoring segment of the market. The New Haven, CT-based company is about a year removed from merging with Transgenomics. The transaction also helped Precipio become a public c...
Source: MDDI - June 20, 2018 Category: Medical Devices Authors: Omar Ford Tags: IVD Testing Source Type: news

Five-year survival rate for most common pancreatic cancer just 3%
The “outrageous” five‐year survival rate in England for patients with the most common type of pancreatic cancer ‐ pancreatic ductal adenocarcinoma (PDAC) ‐ has been revealed for the first time in a study, commissioned by the charity Pancreatic Cancer UK (Source: Nursing Times)
Source: Nursing Times - June 20, 2018 Category: Nursing Source Type: news

Researchers identify method to diagnose cancer in patients with early onset diabetes
(Mayo Clinic) Patients diagnosed with pancreatic cancer can develop elevated blood sugar levels up to three years before their cancer diagnosis, according to the results of a study by Mayo Clinic researchers published the journal Gastroenterology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 20, 2018 Category: Cancer & Oncology Source Type: news

Biologists discover how pancreatic tumors lead to weight loss
(Massachusetts Institute of Technology) A study from MIT and Dana-Farber Cancer Institute offers insight into the weight loss seen in pancreatic cancer patients, and suggests that weight loss may not necessarily affect patients' survival. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 20, 2018 Category: Cancer & Oncology Source Type: news

Possible link found between diabetes and common white pigment
(University of Texas at Austin) In a pilot study by a team of researchers at The University of Texas at Austin, crystalline particles of titanium dioxide -- the most common white pigment in everyday products ranging from paint to candies -- were found in pancreas specimens with Type 2 diabetes, suggesting that exposure to the white pigment is associated with the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 20, 2018 Category: International Medicine & Public Health Source Type: news

Higher OS With Neoadjuvant Chemo-RT in Pancreatic Cancer
In PREOPANC, the 2-year survival rate was significantly higher for patients who received neoadjuvant chemoradiotherapy vs standard care. (Source: CancerNetwork)
Source: CancerNetwork - June 20, 2018 Category: Cancer & Oncology Authors: Cancer Network Editors Source Type: news

Mayo researchers identify method to diagnose pancreatic cancer in patients with early onset diabetes
ROCHESTER, Minn. ? Patients diagnosed with pancreatic cancer can develop elevated blood sugar levels up to three years before their cancer diagnosis, according to the results of a study by Mayo Clinic researchers published the journal Gastroenterology. ?Pancreatic cancer is rapidly fatal after its diagnosis, with average survival of six months,? says Suresh Chari, M.D., [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - June 20, 2018 Category: Hospital Management Source Type: news

Pancreatic cancer survivor: "No one else should be told go home and die"
"The first doctor who saw me told me to go home and die," says a pancreatic cancer survivor who hopes one day no one else will have to hear those words (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 20, 2018 Category: Consumer Health News Source Type: news

Recent - Onset Diabetes Tied to Increased Pancreatic Cancer Risk
Latinos, African - Americans with recent - onset disease have higher risk than those with long - term disease (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 19, 2018 Category: Cancer & Oncology Tags: Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Internal Medicine, Oncology, Journal, Source Type: news

Recent-Onset Diabetes Tied to Increased Pancreatic Cancer Risk
TUESDAY, June 19, 2018 -- Recent-onset diabetes is associated with more than a two-fold greater increase in risk of pancreatic cancer (PC) than long-standing diabetes in African-Americans and Latinos, according to a study published online June 18 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 19, 2018 Category: Pharmaceuticals Source Type: news

Late onset diabetes may be sign of pancreatic cancer
The onset of diabetes in people over 50 years old may be an indicator of pancreatic cancer, according to research published in theJournal of the National Cancer Institute.CNN (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 19, 2018 Category: Endocrinology Source Type: news

Recent-Onset Diabetes May Be Early Sign of Pancreatic Cancer Recent-Onset Diabetes May Be Early Sign of Pancreatic Cancer
African Americans and Latinos with recent-onset diabetes have a much higher risk of developing pancreatic cancer than their counterparts without diabetes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 19, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Pancreatic Cell Size Negatively Relates to Lifespan in Mammals
Species with larger pancreatic cells tend to have shorter lives, according to a study.  (Source: The Scientist)
Source: The Scientist - June 19, 2018 Category: Science Tags: News & Opinion Source Type: news

Mayo Clinic discovers gene mutations linked to pancreatic cancer
(Mayo Clinic) Six genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's according to Mayo Clinic research published in the June 19 edition of the JAMA. However, because researchers found these genetic mutations in patients with no family history of pancreatic cancer, they are recommending genetic testing for all pancreatic cancer patients as the new standard of care. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 19, 2018 Category: International Medicine & Public Health Source Type: news

Mayo Clinic discovers gene mutations linked to pancreatic cancer, calls for expanded testing
ROCHESTER, Minn. ? Six genes contain mutations that may be passed down in families, substantially increasing a person?s risk for pancreatic cancer. That's according to Mayo Clinic research published in the June 19 edition of the JAMA. However, because researchers found these genetic mutations in patients with no family history of pancreatic cancer, they are [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - June 19, 2018 Category: Hospital Management Source Type: news

How AI Is Personalizing Insulin Therapy for Diabetes Patients
Artificial intelligence is increasingly playing a role in healthcare, especially in the diabetes management space. The latest example of this comes from Petah Tikva, Israel-based DreMed Diabetes and Mountain View, CA-based Glooko.  FDA has granted a de novo request for the DreaMed Advisor Pro, an AI-based diabetes treatment decision support software intended to help healthcare providers manage people with Type I diabetes who use insulin pumps and continuous glucose monitoring (CGM). DreaMed Advisor Pro is a cloud-based digital solution generating insulin designed to generate insulin delivery recommendations by analyzi...
Source: MDDI - June 18, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Digital Health Source Type: news

Recent-onset diabetes linked to pancreatic cancer for some minorities
Recent-onset type 2 diabetes has been linked to pancreatic cancer in African Americans and Hispanics older than 50, according to a study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 18, 2018 Category: Consumer Health News Source Type: news

Recent-onset diabetes linked to pancreatic cancer in African-Americans, Hispanics
Recent-onset type 2 diabetes has been linked to pancreatic cancer in African Americans and Hispanics older than 50, according to a study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 18, 2018 Category: Consumer Health News Source Type: news

Diabetes in middle age may be an early sign of pancreatic cancer
University of Southern California researchers claim being diagnosed with type 2 diabetes after the age of 50 could be a sign of pancreatic cancer as rates are higher than in long-term diabetics. (Source: the Mail online | Health)
Source: the Mail online | Health - June 18, 2018 Category: Consumer Health News Source Type: news

Diabetes after 50 could be early sign of pancreatic cancer
The onset of diabetes after the age of 50 could be an early sign of pancreatic cancer, a new study suggests. (Source: CNN.com - Health)
Source: CNN.com - Health - June 18, 2018 Category: Consumer Health News Source Type: news

Diabetes may be an early manifestation of pancreatic cancer
(Oxford University Press USA) A new study in the Journal of the National Cancer Institute indicates that recent-onset type 2 diabetes may be early expression of pancreatic cancer. Diabetes was associated with a more than twofold higher risk of pancreatic cancer in African-Americans and Latinos, but recent-onset diabetes was associated with a 2.3-fold greater increase in risk of pancreatic cancer than long-standing diabetes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 18, 2018 Category: International Medicine & Public Health Source Type: news

Diabetes diagnosis may signal early pancreatic cancer in older African-Americans, Latinos
(University of Southern California - Health Sciences) A new study from the Keck School of Medicine of USC shows that African-Americans and Latinos who are diagnosed with diabetes after age 50 have a more than threefold risk of developing pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 17, 2018 Category: Cancer & Oncology Source Type: news

AMG Int ’ l wins CE Mark for Archimedes bioresorbable biliatric stent
Q3 Medical Devices’ AMG International said today it won CE Mark approval in the European Union for its Archimedes biodegradable biliary and pancreatic stent. The Winsen, Germany-based company touts the Archimedes as the only fully biodegradable biliary and pancreatic stent cleared for use in obstructed biliary or pancreatic ducts globally. “The Archimedes biodegradable stent represents a major breakthrough in the treatment of obstructive biliary and pancreatic disorders, and also in the field of biodegradable and bioresorbable materials and their application in medical devices moving forward. This technology ha...
Source: Mass Device - June 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Regulatory/Compliance Stents amginternational Source Type: news

Should mFOLFIRINOX Be Standard of Care in Adjuvant Tx of Pancreatic Cancer?
Compared with gemcitabine, mFOLFIRINOX improved outcomes for all endpoints when used in the adjuvant setting. (Source: CancerNetwork)
Source: CancerNetwork - June 15, 2018 Category: Cancer & Oncology Authors: Cancer Network Editors Source Type: news

Pancreatic cancer patients with BRCA mutation may benefit from targeted drug
(University of Arizona Health Sciences) Rachna Shroff, M.D., led a landmark study on the use of targeted drugs called PARP inhibitors in pancreatic cancer patients with BRCA mutations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2018 Category: International Medicine & Public Health Source Type: news

Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases
The majority of patients with pancreatic ductal adenocarcinoma (PDA) develop metastatic disease after resection of their primary tumor. We found that livers from patients and mice with PDA harbor single disseminated cancer cells (DCCs) lacking expression of cytokeratin 19 (CK19) and major histocompatibility complex class I (MHCI). We created a mouse model to determine how these DCCs develop. Intraportal injection of immunogenic PDA cells into preimmunized mice seeded livers only with single, nonreplicating DCCs that were CK19– and MHCI–. The DCCs exhibited an endoplasmic reticulum (ER) stress response but parad...
Source: ScienceNOW - June 14, 2018 Category: Science Authors: Pommier, A., Anaparthy, N., Memos, N., Kelley, Z. L., Gouronnec, A., Yan, R., Auffray, C., Albrengues, J., Egeblad, M., Iacobuzio-Donahue, C. A., Lyons, S. K., Fearon, D. T. Tags: Medicine, Diseases, Online Only r-articles Source Type: news

The medicine keeping her alive was also killing her
Emmy Reeves had type 1 diabetes, but she was allergic to the insulin she needed to stay alive. She recently became the first child in nearly 20 years to undergo a pancreas transplant. What happened next was incredible. (Source: CNN.com - Health)
Source: CNN.com - Health - June 12, 2018 Category: Consumer Health News Source Type: news

Pancreas Divisum Ups Pancreatitis Risk in Kids (CME/CE)
(MedPage Today) -- Linked to both acute recurrent and chronic pancreatitis (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 12, 2018 Category: Gastroenterology Source Type: news

Neoadjuvant CRT May Improve Survival in Pancreatic Cancer Neoadjuvant CRT May Improve Survival in Pancreatic Cancer
Results are preliminary, but patients who received neoadjuvant chemoradiation had better outcomes than did those who had immediate surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 8, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Beta Bionics and Senseonics Collaborate on AI-Driven Pancreas
Just a few weeks after Beta Bionics made headlines with an IDE approval for its artificial intelligence (AI) driven iLet bionic pancreas system, the company is in the spotlight again. This time, Beta Bionics is teaming up with Senseonics Holdings, a company that is developing an implantable continuous glucose monitoring (CGM) system. Under this agreement, Beta Bionics will integrate Germantown, MD-based Senseonics’ Eversense CGM system with the iLet. Real-time data generated by Eversense could serve as one CGM option to drive the fully autonomous iLet Bionic Pancreas system. The iLet consists of a dual-chamber, auton...
Source: MDDI - June 8, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news

Long-term exposure to arsenic increases your risk of diabetes
(Natural News) According to the alarming results of a report, it may be time to double-check the quality of your water supply. The findings have revealed that long-term exposure to arsenic “interferes with insulin secretion in the pancreas, which may increase the risk of diabetes.” The report was published in the American Journal of Physiology—Regulatory, Integrative... (Source: NaturalNews.com)
Source: NaturalNews.com - June 8, 2018 Category: Consumer Health News Source Type: news

Novel PET tracer shows promise for neuroendocrine tumors
The ability to detect cancerous gastrointestinal and pancreatic neuroendocrine...Read more on AuntMinnie.comRelated Reading: SNMMI: PET/CT with Ga-68 DOTATOC targets neuroendocrine tumors Ga-68 DOTATOC PET/MRI tops PET/CT for staging neuroendocrine tumors SNM Image of the Year goes to Bi-123 DOTATOC radiotracer DOTA-NOC-PET/CT aids neuroendocrine tumor treatment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 7, 2018 Category: Radiology Source Type: news

Nine Cancers Linked to Diabetes Risk Nine Cancers Linked to Diabetes Risk
A diagnosis of pancreatic cancer was associated with the largest elevation in diabetes risk, increasing five-fold in the first 2 years after diagnosis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 7, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Cancer Diagnosis Linked to Elevated Risk for Diabetes
(MedPage Today) -- Highest risk for pancreatic cancer (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 7, 2018 Category: Hematology Source Type: news

Beta Bionics taps Senseonics ’ implantable glucose monitor for artificial pancreas
Senseonics‘ (NYSE:SENS) said today that it inked a deal to integrate glucose data from its Eversense continuous glucose monitoring system into Beta Bionics‘ investigational iLet bionic pancreas. According to the terms of the development agreement, Beta Bionics and Senseonics will work together to combine the two systems in the hopes of driving insulin and glucagon dosing with real-time data from the Eversense monitor. Get the full story at our sister site, Drug Delivery Business News. The post Beta Bionics taps Senseonics’ implantable glucose monitor for artificial pancreas appeared first on MassDevi...
Source: Mass Device - June 7, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat Beta Bionics Senseonics Source Type: news

Turning Surgeons Into Innovators Without Taking Them Out of the OR
Academic hospitals have all the makings for rich medical device development. They have physicians to identify surgical needs, researchers to test theories, bioengineers to design and create devices and patients to participate in clinical trials. However, disconnect between engineering and surgical departments makes innovation a challenge. So does surgeons' all-consuming job Number One—treating patients. Surgical Innovations, part of the University of California, San Francisco's Department of Surgery and Bioengineering & Therapeutic Sciences, aims to open communication between clinical academic surgeons and bioeng...
Source: MDDI - June 6, 2018 Category: Medical Devices Authors: Heather R. Johnson Tags: R & D Source Type: news

Is It Possible To Eat Too Much Fruit?
Apple co-founder Steve Jobs was, briefly and famously, an ardent fruitarian—meaning he ate a diet composed primarily of fruit, which he believed would cleanse his body of harmful fluids. Just as famously, the actor Ashton Kutcher tried adopting Jobs’s fruit-centric diet, until he ended up in the hospital with an out-of-whack pancreas. So is it bad for your health to eat a lot of fruit? Though a famous study from 1980 argued that based on the evolution of human jaws and teeth, our ancient ancestors used to eat a diet dominated by fruit, there’s not a lot of good evidence for or against fruit-heavy diets fo...
Source: TIME: Health - June 6, 2018 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Diet/Nutrition healthytime Source Type: news

New nuclear medicine method shows promise for better detection of neuroendocrine tumors
(Society of Nuclear Medicine and Molecular Imaging) Researchers have shown that a new nuclear medicine procedure could safely and more effectively detect cancerous gastrointestinal and pancreatic neuroendocrine tumors than current methods. The study is featured in the June issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 6, 2018 Category: Cancer & Oncology Source Type: news

VIDEO: Pancreatic Ca Gets 20-Month Survival Boost
(MedPage Today) -- Aggressive post-surgery chemo regimen touted as new standard of care (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 5, 2018 Category: Gastroenterology Source Type: news

Pancreatic Ca Gets 20-Month Survival Boost
(MedPage Today) -- Aggressive post-surgery chemo regimen touted as new standard of care (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 5, 2018 Category: Gastroenterology Source Type: news

More Patients Are Dead After Weight-Loss Balloon Surgery
FDA is still keeping tabs on two liquid-filled intragastric balloon systems used to treat obesity as at least a dozen patients have died in the past two years after receiving one of the devices. The agency first alerted physicians about deaths possibly associated with the devices last year after five patient deaths had been reported. FDA has also approved labeling changes to reflect this information. The agency said it also continues to monitor complications related to the placement and use of these devices, including perforation of the stomach wall or esophagus, inflammation of the pancreas, and the balloon filling with a...
Source: MDDI - June 5, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

New Treatments May Extend Pancreatic Cancer Survival
Title: New Treatments May Extend Pancreatic Cancer SurvivalCategory: Health NewsCreated: 6/4/2018 12:00:00 AMLast Editorial Review: 6/5/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 5, 2018 Category: Cancer & Oncology Source Type: news

Pre-Surgical CRT May Boost Survival in Pancreatic Ca
(MedPage Today) -- Further data needed to clarify best approach and who would benefit most (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - June 5, 2018 Category: Radiology Source Type: news

New Treatments May Extend Pancreatic Cancer Survival
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - June 5, 2018 Category: Cancer & Oncology Source Type: news